Hemodynamic Alterations in Patients with End-Stage Chronic Kidney Disease UndergoingHemodialysis

LAS ALTERACIONES HEMODINÁMICAS EN PACIENTES CON ENFERMEDAD RENAL CRÓNICA TERMINAL SOMETIDOS A HEMODIÁLISIS

Authors

DOI:

https://doi.org/10.57188/ricsa.2025.034

Keywords:

End-Stage Renal Disease; Hemodialysis; Hypotension; Hemodynamics; Cardiovascular Diseases

Abstract

End-stage chronic kidney disease causes significant alterations in the cardiovascular system, particularly in patients undergoing hemodialysis. Although this procedure is essential for removing toxins and regulating body fluid volume, it induces important hemodynamic changes that affect blood pressure and cardiac output. The most common complication is intradialytic hypotension, which may occur in multiple sessions and lead to dizziness, hypoperfusion of vital organs, and progressive clinical deterioration. This review aimed to describe the main hemodynamic changes associated with hemodialysis, explain the underlying pathophysiological mechanisms, and analyze the factors that compromise stability during treatment. It also examined interventions that may improve patient tolerance, including gradual adjustment of dry weight, the use of cooler dialysate solutions, nutritional assessment, and—in selected cases—techniques such as hemodiafiltration. Individualizing therapy according to each patient’s condition can reduce risks and optimize quality of life.

 

Downloads

Download data is not yet available.

References

1. Daugirdas JT. Dialysis hypotension: A hemodynamic imbalance? Am J Kidney Dis. 2021;77(2):183–5. doi:10.1053/j.ajkd.2020.10.013

2. Kanbay M, Ertuglu LA, Afsar B, Ozdogan E, Siriopol D, Covic A, et al. An update review of intradialytic hypotension: Concept, risk factors, clinical implications and management. Clin Kidney J. 2020;13(6):981–93. doi:10.1093/ckj/sfaa167

3. Flythe JE, Assimon MM, Overgaard-Steensen C, Wong MMY, et al. Blood pressure and volume management in dialysis: Conclusions from a KDIGO Controversies Conference. Clin J Am Soc Nephrol. 2020;15(3):398–408. doi:10.2215/CJN.09780819

4. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, et al. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine in hemodialysis patients. Clin J Am Soc Nephrol. 2021;16(10):1555–64. doi:10.2215/CJN.02490221

5. Alkhouli M, Boobes K, Hatahet K, Raza F, Boobes Y. Complicaciones cardiacas de las fístulas arteriovenosas en pacientes con enfermedad renal terminal. Nefrología. 2015;35(3):234–45. doi:10.1016/j.nefro.2015.03.006

6. Coto Porras MI. Estratificación del riesgo cardiovascular en el paciente con enfermedad renal crónica en hemodiálisis [tesis]. San José (CR): Universidad de Costa Rica; 2024.

7. Timofte D, Tanasescu MD, Balan DG, Tulin A, et al. Management of acute intradialytic cardiovascular complications: Updated overview (Review). Exp Ther Med. 2021;21(3):282. doi:10.3892/etm.2021.9713

8. Righetti M, Ferrario M, Milani S. Hemodynamic monitoring during dialysis: Clinical implications. Int J Artif Organs. 2023;46(1):11–9. doi:10.1177/03913988221147363

9. Burton JO, Graham-Brown MPM, Patel AS, et al. Ischemic brain injury during hemodialysis. Clin J Am Soc Nephrol. 2021;16(7):1040–8. doi:10.2215/CJN.17771120

10. Basile C, Lomonte C. The complex relationship among arteriovenous access, heart, and circulation. Semin Dial. 2018;31(1):15–20. doi:10.1111/sdi.12653

11. Pereira-García M, Fernández-Prado R, Avelló-Escribano A, González-Parra E. Análisis de la ultrafiltración media por sesión en pacientes de una unidad de hemodiálisis. Enferm Nefrol. 2020;23(2):192–7. Disponible en: https://revistaenfermerianefrologica.com

12. Leal-Escobar G, Osuna-Padilla IA, Vásquez-Jiménez E, Cano-Escobar KB. Nutrición y diálisis peritoneal: Fundamentos y aspectos prácticos para la prescripción dietética. Rev Med Inst Mex Seguro Soc. 2021;59(4):330–8. Disponible en: http://revistamedica.imss.gob.mx

13. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF-36 quality-of-life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol. 2001;12(12):2797–806. Disponible en: https://jasn.asnjournals.org

14. Jin DC. Dialysis registries in the Republic of Korea: Historical perspective with a focus on end-stage kidney disease. Kidney Res Clin Pract. 2021;40(4):475–81. doi:10.23876/j.krcp.21.095

15. Wang AY, et al. Hemodiafiltration and cardiovascular outcomes: A meta-analysis of randomized trials. Am J Kidney Dis. 2024;83(2):123–34. doi:10.1053/j.ajkd.2023.06.017

Downloads

Published

2026-01-26

Issue

Section

Contribuciones especiales

How to Cite

Hemodynamic Alterations in Patients with End-Stage Chronic Kidney Disease UndergoingHemodialysis: LAS ALTERACIONES HEMODINÁMICAS EN PACIENTES CON ENFERMEDAD RENAL CRÓNICA TERMINAL SOMETIDOS A HEMODIÁLISIS. (2026). RICSA, 2(4), 240-243. https://doi.org/10.57188/ricsa.2025.034